Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Clinical Outcomes in Bloodstream Infections With Carbapenem Hetero-resistant vs Carbapenem Resistant Klebsiella Pneumoniae (COMBAT)

NCT04229498 is registered in ClinicalTrials.gov with SCARE (Study group for carbapenem resistance) as lead sponsor.

NCT NCT04229498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04229498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Clinical Outcomes in Bloodstream Infections With Carbapenem Hetero-resistant vs Carbapenem Resistant Klebsiella Pneumoniae (COMBAT)
Lead sponsor
SCARE (Study group for carbapenem resistance)
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2020
Completion date
November 30, 2021
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bloodstream infection